Chemoinformaics analysis of (2R,3S,4S,5R)-5-HYDROXY-2,3,4,6-TETRAMETHOXYHEXANAL
| Molecular Weight | 236.264 | nRot | 9 |
| Heavy Atom Molecular Weight | 216.104 | nRig | 1 |
| Exact Molecular Weight | 236.126 | nRing | 0 |
| Solubility: LogS | 0.12 | nHRing | 0 |
| Solubility: LogP | -0.976 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 34.8479 |
| nHD | 1 | BPOL | 27.8761 |
| QED | 0.53 |
| Synth | 4.245 |
| Natural Product Likeliness | 1.157 |
| NR-PPAR-gamma | 0.016 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.319 |
| HIA | 0.811 |
| CACO-2 | -4.891 |
| MDCK | 0.0000987 |
| BBB | 0.109 |
| PPB | 0.238567 |
| VDSS | 0.556 |
| FU | 0.765538 |
| CYP1A2-inh | 0.003 |
| CYP1A2-sub | 0.459 |
| CYP2c19-inh | 0.005 |
| CYP2c19-sub | 0.389 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.012 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.129 |
| CYP3a4-inh | 0.009 |
| CYP3a4-sub | 0.269 |
| CL | 4.007 |
| T12 | 0.355 |
| hERG | 0.075 |
| Ames | 0.153 |
| ROA | 0.018 |
| SkinSen | 0.399 |
| Carcinogencity | 0.016 |
| EI | 0.054 |
| Respiratory | 0.015 |
| NR-Aromatase | 0.52 |
| Antiviral | No |
| Prediction | 0.834186 |